Elsevier

Oral Oncology

Volume 114, March 2021, 105069
Oral Oncology

Letter to the editor
Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic

https://doi.org/10.1016/j.oraloncology.2020.105069Get rights and content

Highlights

  • Metronomic therapy – advantage of ease of administration, safety, and compliance.

  • We have successfully avoided disease progression in resectable disease.

  • During COVID-19 pandemic, metronomic therapy is a boon in oral cancer patients.

Cited by (0)

View Abstract